These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 17030119)

  • 1. [Campylobacter jejuni and cytomegalovirus (CMV) infections in patients with the Guillain-Barre syndrome].
    Orlikowski D; Quijano-Roy S; Sivadon-Tardy V; Raphael JC; Gaillard JL
    Arch Pediatr; 2006 Dec; 13(12):1561-5. PubMed ID: 17030119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
    Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
    Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and characteristics of Guillain-Barré syndromes associated with Campylobacter jejuni and cytomegalovirus in greater Paris].
    Sivadon V; Orlikowski D; Rozenberg F; Quincampoix JC; Caudie C; Durand MC; Fauchère JL; Sharshar T; Raphaël JC; Gaillard JL
    Pathol Biol (Paris); 2005; 53(8-9):536-8. PubMed ID: 16084033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barre syndrome in children.
    Tabarki-Melaiki B
    Neurosciences (Riyadh); 2011 Apr; 16(2):174-5. PubMed ID: 21427674
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome.
    Sinha S; Prasad KN; Pradhan S; Jain D; Jha S
    Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):342-6. PubMed ID: 15099989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000-2001.
    Tam CC; Rodrigues LC; O'Brien SJ
    Clin Infect Dis; 2003 Jul; 37(2):307-10. PubMed ID: 12856224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
    Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
    Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
    Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
    J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.
    Geleijns K; Jacobs BC; Van Rijs W; Tio-Gillen AP; Laman JD; van Doorn PA
    J Neuroimmunol; 2004 May; 150(1-2):132-8. PubMed ID: 15081257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guillain-Barre syndrome: etiology and pathogenesis].
    Avila-Funes JA; Mariona-Montero VA; Melano-Carranza E
    Rev Invest Clin; 2002; 54(4):357-63. PubMed ID: 12415961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome: association with Campylobacter jejuni and Mycoplasma pneumoniae infections in India.
    Gorthi SP; Kapoor L; Chaudhry R; Sharma N; Perez-Perez GI; Panigrahi P; Behari M
    Natl Med J India; 2006; 19(3):137-9. PubMed ID: 16836263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Campylobacter jejuni infection and GuillainBarré syndrome: a cohort study in the northwest of Iran.
    Barzegar M; Alizadeh A; Toopchizadeh V; Dastgiri S; Majidi J
    Turk J Pediatr; 2008; 50(5):443-8. PubMed ID: 19102048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Campylobacter jejuni infection with childhood Guillain-Barré syndrome: a case-control study.
    Kalra V; Chaudhry R; Dua T; Dhawan B; Sahu JK; Mridula B
    J Child Neurol; 2009 Jun; 24(6):664-8. PubMed ID: 19491112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case control study in a tertiary care hospital.
    Sharma A; Lal V; Modi M; Vaishnavi C; Prabhakar S
    Neurol India; 2011; 59(5):717-21. PubMed ID: 22019657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome and acute motor axonal neuropathy after Campylobacter jejuni infection.
    Rajabally YA; Ramlackhansingh A; Fraser M; Abbott RJ
    Neurophysiol Clin; 2009 Aug; 39(3):135-8. PubMed ID: 19716463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barre syndrome and Campylobacter infection.
    Prasad KN; Pradhan S; Nag VL
    Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):527-30. PubMed ID: 11944711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
    Hagensee ME; Benyunes M; Miller JA; Spach DH
    Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.
    Caporale CM; Papola F; Fioroni MA; Aureli A; Giovannini A; Notturno F; Adorno D; Caporale V; Uncini A
    J Neuroimmunol; 2006 Aug; 177(1-2):112-8. PubMed ID: 16820217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Campylobacter jejuni infection in patient with Guillain-Barré syndrome: a case report].
    Kopyta I; Wardak S
    Med Dosw Mikrobiol; 2008; 60(1):59-63. PubMed ID: 18634345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.